Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Abiraterone News Monitoring

Get by Email • RSS

Published on 10:58 GMT

TLX591 Antibody-Based Lutetium-177 PSMA Therapy in Metastatic CRPC - Pedro Barata

Neeraj Agarwal: Hello, welcome to UroToday. My name is Dr. Neeraj Agarwal. I'm a professor of medicine and medical oncology at the Huntsman Cancer Institute, University of Utah. It's such a pleasure to have a dear friend, Dr. Pedro Barata, who is …

Source: UroToday - Neutral
Published on Aug 4, 2026

ORIC Q2 Loss Widens As Phase 3 Trial For Prostate Cancer Progresses; Stock Down

(RTTNews) - ORIC Pharmaceuticals, Inc. (ORIC), a clinical-stage oncology company, reported a wider net loss for the second quarter ended June 30, 2026, and provided updates on its clinical pipeline. Company Profile ORIC Pharmaceuticals is a clinical-stage …

Source: Nasdaq - Neutral
Published on Aug 5, 2026

AMGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS

Amgen (NASDAQ: AMGN) today announced financial results for the second quarter of 2026. "Our results demonstrate strong performance across our business. Our six key growth drivers grew 26% year over year, generating nearly 70% of second-quarter product …

Source: Investing News Network - Neutral
Published on Jul 31, 2026

<![CDATA[FDA OKs Lutetium Lu 177 Vipivotide Tetraxetan in Metastatic Prostate Cancer]]>

The FDA has approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto) plus an androgen receptor pathway inhibitor (ARPI) for patients with prostate-specific membrane antigen (PSMA)–positive androgen pathway modulation-naïve or-sensitive prostate cancer, …

Source: Cancer Network - Pending
Published on Aug 1, 2026

<![CDATA[FDA Approves Pluvicto for PSMA+ mAPMN/S Prostate Cancer]]>

The U.S. Food and Drug Administration (FDA) has announced the approval of lutetium Lu 177 vipivotide tetraxetan (Pluvicto, Novartis Pharmaceuticals Corporation) for use in combination with androgen receptor pathway inhibitor (ARPI) therapy. This new …

Source: Oncology Nursing News - Pending
Published on Jul 31, 2026

Prostate Cancer Foundation joins call to unlock lifechanging medicines for patients nationwide

The Prostate Cancer Foundation NZ (PCFNZ) is backing a major public awareness campaign that shows the human impact of New Zealand’s medicines access crisis. As part of its ongoing advocacy for better access to medicines, PCFNZ is supporting The Forbidden …

Source: New Zealand Doctor - Neutral
Published on Jul 30, 2026

The Small Prostate Cancer Trial Behind Adaptive Therapy, and the Dispute Over What It Proved

What the Trial Actually Did The idea behind adaptive cancer therapy is counterintuitive enough that it needs stating plainly: give less of a drug, on purpose, and the cancer may take longer to become resistant to it. The pilot study that put that idea into …

Source: Medical Daily - Indeterminate
Published on Jul 30, 2026

PARP Inhibitors for Prostate Cancer: 5 Things to Know

Prostate cancer is the second most common cancer in men worldwide, with nearly 1.4 million new cases diagnosed each year. PARP inhibitors have transformed the treatment landscape for biomarker‑selected metastatic disease, moving from experimental agents to …

Source: Medscape - Neutral
Published on Jul 31, 2026

<![CDATA[FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC]]>

The FDA has approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto) plus an androgen receptor pathway inhibitor (ARPI) for the treatment of adult patients with prostate-specific membrane antigen (PSMA)–positive metastatic androgen pathway modulation– …

Source: OncLive - Pending
Published on Jul 27, 2026

<![CDATA[Volume, Biomarkers, and Cost Realities Guide ARPI Sequencing in Advanced Prostate Cancer]]>

When a man with newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) walks into clinic today, the default is no longer androgen-deprivation therapy (ADT) alone but ADT plus an androgen-receptor pathway inhibitor (ARPI), with debate now …

Source: OncLive - Pending
Published on Aug 1, 2026

<![CDATA[Individualizing androgen pathway therapy in mCSPC]]>

Treatment options for metastatic castration-sensitive prostate cancer (mCSPC), a disease state increasingly referred to as androgen pathway modifier-sensitive prostate cancer under the terminology adopted by Prostate Cancer Working Group 4, have expanded …

Source: Urology Times - Pending
Published on Jul 25, 2026

#hauora: Prostate Cancer Foundation Joins Call to End New Zealand’s Medicines Gap

The Prostate Cancer Foundation New Zealand (PCFNZ) is backing a nationwide campaign aimed at exposing what it says is a growing medicines access crisis, with hundreds of treatments available overseas still out of reach for New Zealand patients. The …

Source: Waatea News - Left-wing
Published on Jul 22, 2026

<![CDATA[Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional ...

INTRODUCTION In 2022, prostate cancer was estimated to be the most diagnosed malignancy among men in Mexico, accounting for 26,565 new cases and 7358 deaths.1 Mexican men with prostate cancer experience significant disparities in access to advanced health …

Source: Cancer Network - Pending
Published on Jul 21, 2026

Researchers Develop a Fully Human Antibody That Halted Aggressive Prostate Cancer Growth and Spread in Lab Models

Researchers at Umeå University in Sweden and international collaborators have developed a fully human antibody that blocked both tumor growth and metastatic spread in preclinical models of aggressive prostate cancer through a mechanism targeting a protein …

Source: Medical Daily - Indeterminate
Published on Jul 22, 2026

<![CDATA[How Are Treatment Intensification and Sequencing Reshaping Care in Prostate Cancer and RCC]]>

Androgen deprivation therapy (ADT) was "all we had" for generations in prostate cancer, but management now looks unrecognizable from just a few years ago, Mark Pomerantz, MD, of Dana-Farber Cancer Institute, said during a recent OncLive® Fellows …

Source: OncLive - Pending
Published on Jul 21, 2026

TRIPLE-SWITCH and Personalizing Therapy in Metastatic Hormone-Sensitive Prostate Cancer - Michael Ong

Zachary Klaassen: Hi, my name is Zach Klaassen, urologic oncologist in Augusta, Georgia, and I'm on UroToday at ASCO 2026 in Chicago with Dr. Michael Ong, who's a medical oncologist at the Ottawa Hospital Cancer Center. Today we'll be …

Source: UroToday - Neutral
Published on Jul 16, 2026

UK Clears First Precision Pill for BRCA-Mutated Prostate Cancer: NICE Now Decides

For the roughly one in ten British men with metastatic prostate cancer who carry BRCA1 or BRCA2 gene mutations, Wednesday brought the news oncologists have been waiting for: the UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted …

Source: Tech Times - Neutral
Published on Jul 27, 2026

Busworkers support Cancer Research strikers

STRIKERS at the Institute of Cancer Research in Chelsea West London yesterday were joined by bus drivers from Westbourne Park bus garage, who are fellow Unite members, who were raising awareness about bus drivers fatigue. Chris Starling, a higher …

Source: The News Line - Left-wing
Published on Jul 15, 2026

<![CDATA[Biomarker-guided PARP inhibition shows durable benefit in hormone-sensitive prostate cancer]]>

The TALAPRO-3 trial clinical trial published at the end of May in the New England Journal of Medicine found that adding the PARP inhibitor talazoparib to enzalutamide significantly extended progression-free survival in men with metastatic hormone-sensitive …

Source: Managed Healthcare Executive - Neutral

04 days 13:16:30

Featured Releases

Got News to Share? · Submit · See All

Published on August 6, 2026 - 11:01 GMT

Tarsus Pharmaceuticals to Acquire Alkeus Pharmaceuticals and Advance Eye Care Leadership Position

Adds a potential blockbuster opportunity with gildeuretinol (ALK-001), a differentiated Phase 3 oral investigational medicine designed to target the underlying biology of Stargardt disease, one of the largest inherited retinal diseases with no FDA-approved …

Distribution channels:
Published on August 6, 2026 - 11:02 GMT

Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

IRVINE, Calif., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (Nasdaq: TARS) (“Tarsus”) today announced that it has entered into a securities purchase agreement with certain qualified institutional buyers and accredited investors for a …

Distribution channels:

Published on August 6, 2026 - 12:00 GMT

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

CONSHOHOCKEN, Pa., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced today that the company will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, Aug. 11, 2026 at 12:00 P.M. EDT. The …

Distribution channels:
Published on August 6, 2026 - 14:16 GMT

New in Health Affairs Forefront: 'Myths of Mandatory International Reference Pricing for Prescription Drugs'

A new article from the National Pharmaceutical Council includes evidence to dispel common myths about mandatory international reference pricing. WASHINGTON, DC, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- A new Health Affairs Forefront …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 6, 2026 - 06:40 GMT

Top Therapeutic And Pharmaceutical Peptides Manufacturer Expands Innovation in Global Peptide Solutions

SHANGHAI, CHINA, August 6, 2026 /⁨EINPresswire.com⁩/ -- As the global biotechnology industry continues to advance, **Shanghai Sunite Biotechnology Co., Ltd.** has strengthened its position as a leading Therapeutic and Pharmaceutical Peptides …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on August 6, 2026 - 11:30 GMT

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates

Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027 NDA resubmission activities for ZYNQUISTA® in type 1 diabetes nearing completion Phase 1 clinical development of LX9851 ongoing by Novo Nordisk Conference call and webcast at …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 12:00 GMT

Corbus Pharmaceuticals Reports Q2 2026 Financial Results and Provides a Corporate Update

Obtained FDA clearance to proceed with registrational study (TEMPO-1) of CRB-701 in 2L oropharyngeal cancer and expect to initiate enrollment in September 2026 Concluded last patient last visit in CANYON-1 Phase 1b study (n=240) of CRB-913 in obesity and …

Distribution channels: Business & Economy, Technology ...
Published on August 6, 2026 - 12:00 GMT

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Obesity Treatment Candidate Designed to Preserve Lean Body Mass Toxicokinetic Findings De-Risk Dose Selection and Support Regulatory Pathway Toward IND MIAMI, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 932,221,593 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 07/12/2026

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on August 6, 2026 - 14:38 GMT

Play With Heart Foundation Partners with Response Ready to Donate AEDs to Point Break Volleyball Club

Two AED donations strengthens cardiac emergency preparedness as California youth sports prepare for new AED and CPR requirements. SAN DIEGO, CA, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Play With Heart Foundation, a 501(c)(3) …

Distribution channels: Building & Construction Industry, Culture, Society & Lifestyle ...
Published on August 6, 2026 - 14:22 GMT

Wellness Trends Shift Beyond Exercise as More People Seek to Better Understand How They Move

BOSTON, MA, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- As conversations around health and wellbeing continue to evolve, movement specialists are observing a shift in how people approach exercise. Increasingly, the focus is moving beyond …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on August 6, 2026 - 14:19 GMT

Ascension Recovery Services Develops New Tribal Lands Initiative Through Partnership with ECHAGA Corporation

National Tribal lands partnership advances plans for a 48-bed adolescent behavioral health and residential treatment facility serving Oglala Lakota youth PINE RIDGE RESERVATION, SD, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Ascension …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 14:16 GMT

New in Health Affairs Forefront: 'Myths of Mandatory International Reference Pricing for Prescription Drugs'

A new article from the National Pharmaceutical Council includes evidence to dispel common myths about mandatory international reference pricing. WASHINGTON, DC, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- A new Health Affairs Forefront …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 14:13 GMT

Vertikal6 Named to Providence Business News' 2026 Fastest Growing Companies List

Recognition in the $15 million–$50 million Revenue Category Reflects Continued Growth in Managed Services, Cybersecurity, AI Innovation and CMMC Readiness PROVIDENCE, RI, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Vertikal6, a leading …

Distribution channels: Banking, Finance & Investment Industry, Food & Beverage Industry ...
Published on August 6, 2026 - 14:00 GMT

LTCareNav Adds CarePatrol’s Nationwide Network of Senior Care Advisors to Its Family Planning Platform

Exclusive US partnership means families and the caregivers who love them now have access to trusted, local human guidance — exactly when they need it most CLEVELAND, OH, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- LTCareNav, a digital …

Distribution channels: Business & Economy, Companies ...
Published on August 6, 2026 - 14:00 GMT

PurpleLab Wins the 'Cross-Channel Measurement Platform of the Year' MarTech Breakthrough Award

PurpleLab has been recognized for leading innovation in healthcare marketing measurement, reshaping how brands engage, convert, and grow. NEW YORK, NY, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- PurpleLab®, a leading provider of real- …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 14:00 GMT

ALEX'S LEMONADE STAND FOUNDATION FILLS CRITICAL GAP WITH FIRST-EVER COMPREHENSIVE CHILDHOOD CANCER REPORT

A Landmark Independent Reference for Families, Advocates & Journalists is Now Accessible as the Stakes for Pediatric Cancer Research Have Never Been Higher WYNNEWOOD, PA, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Alex's …

Distribution channels: Emergency Services, Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 14:00 GMT

Creative Interventions Receives Accreditation from Autism Commission on Quality (ACQ)

LOUISVILLE, KY, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- The Autism Commission on Quality (ACQ) has awarded a full two-year accreditation to Creative Interventions for its applied behavior analysis (ABA) programs in Connecticut and …

Distribution channels: Companies, Consumer Goods ...
Published on August 6, 2026 - 14:00 GMT

Rampart Prevails in Patent Review Initiated by Egg Medical on Key Claims Related to Radiation Protection Products

USPTO confirms patentability of Rampart’s claims following appeal, affirming protection for its innovative radiation-shielding technology BIRMINGHAM, AL, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Birmingham, AL — August 6, 2026 — …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 13:51 GMT

Stand Up for Science Condemns Latest Round of NIH Grant Cancellations

Terminations of National Institutes of Health grants target health disparities research; more cancellations expected WASHINGTON DC, DC, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Today, Stand Up for Science is responding to the news, as …

Distribution channels: Healthcare & Pharmaceuticals Industry, Politics ...
Published on August 6, 2026 - 13:46 GMT

Refresh - Aesthetics & Wellness Launches "Know Your Vial" Botox Safety Initiative in Florida

New patient education program addresses counterfeit Botox, authorized sourcing, provider credentials and medical oversight before cosmetic injections. JUPITER, FLORIDA, FL, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Refresh - Aesthetics …

Distribution channels: Beauty & Hair Care, Business & Economy ...
Published on August 6, 2026 - 13:45 GMT

Harmony Diet Review: A Personalized Wellness App for Menopause

Inside the Harmony Diet app, women are calling it a relief for menopause – reviews, features, and what sets it apart. NEW YORK, NY, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Harmony Diet is introducing a wellness program developed to …

Distribution channels: Beauty & Hair Care, Culture, Society & Lifestyle ...
Published on August 6, 2026 - 13:30 GMT

Goodfeelcare Expands Online Availability Through Amazon India, Strengthening Access to Premium Feminine Hygiene Products

The Indian feminine hygiene brand announces the availability of its premium sanitary pads on Amazon India KAITHAL, HARYANA, INDIA, August 6, 2026 /⁨EINPresswire.com⁩/ -- Goodfeelcare, an Indian feminine hygiene brand committed to supporting women…

Distribution channels: Beauty & Hair Care, Education ...
Published on August 6, 2026 - 13:30 GMT

104 Matches, Three Countries, One Operation: HMP Global's EMS World Expo Keynote Goes Inside the 2026 FIFA World Cup

Dr. Eric Ossmann, 2026 FIFA World Cup Director of Medical Administration, will kick off the 7000-person event in Orlando, Sept 28 to Oct 2, MALVERN, PA, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- The 2026 FIFA World Cup required a …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on August 6, 2026 - 13:16 GMT

Olive Mill Water Company Launches Beverage Made From Olive Oil By-Product Being Called the Next Superfood

For decades, an olive by‑product was discarded as waste. Now it’s being called a superfood, and consumers can finally access it. ALBERT PARK, VICTORIA, AUSTRALIA, August 6, 2026 /⁨EINPresswire.com⁩/ -- A long-neglected food ingredient is rapidly …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on August 6, 2026 - 13:15 GMT

NAYA SELECTED AS A GOOD HOUSEKEEPING 2026 PARENTING AWARDS WINNER

DENVER, CO, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- Naya, announced today that its free, AI- and MD-powered web app for fourth trimester support was named a winner in Good Housekeeping’s 2026 Parenting Awards. The full list of awards …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on August 6, 2026 - 13:15 GMT

The MEDICE Health Family advances unified approach to regulated content operations across European affiliates

Specialty pharmaceutical group expands use of Vodori to standardize content governance and connect approved materials with Salesforce’s Agentforce Life Sciences CHICAGO, IL, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- The MEDICE Health …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on August 6, 2026 - 13:15 GMT

The 4th Annual Healthspan Summit 2026 Unites Leaders in Longevity Medicine, Regenerative Aesthetics, & Human Performance

Registration is now open for the curated gathering of clinicians, founders, investors, researchers, and innovators shaping the future of longevity. LOS ANGELES, CA, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- The Healthspan Collective …

Distribution channels: Beauty & Hair Care, Conferences & Trade Fairs ...
Published on August 6, 2026 - 13:00 GMT

PCMS Expands Partner Ecosystem With accūrō Solutions to Strengthen Medical Bill Review and Managed Care for P&C Carriers

Partnership accelerates digital transformation for P&C insurers by unifying bill review and managed care within a modern, cloud‑based ecosystem. DALLAS, TX, UNITED STATES, August 6, 2026 /⁨EINPresswire.com⁩/ -- PCMS, a leading provider of …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...